SCHEMBL30209593

SCHEMBL30209593

Cc1ncnc2ccc(-c3cnc(N)nc3-c3cccs3)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 4/20 0.48
▸ ADORA1 P30542 5/20 0.41
▸ ADORA2A P29274 3/20 0.41
▸ AKT1 P31749 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ APEX1 P27695 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CASP7 P55210 2/20 0.39
▸ CLK4 Q9HAZ1 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RIPK2 O43353 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28343110 1.00 ADK (0.48) ADKADORA1ADORA2AAKT1ROCK1
SCHEMBL29947093 0.83 ADORA1 (0.61) ADORA1ADORA2ATGFBR1LCKKDR
SCHEMBL28345882 0.83 ADORA1 (0.61) ADORA1ADORA2ATGFBR1LCKKDR
SCHEMBL29947057 0.80 ADORA1 (0.55) ADORA1ADORA2ATGFBR1
SCHEMBL21621288 0.80 ADORA1 (0.55) ADORA1ADORA2ATGFBR1
SCHEMBL23965690 0.80 ADORA1 (0.47) ADORA1ADORA2ATGFBR1LCKKDR
SCHEMBL21621289 0.78 ADORA2A (0.53) ADORA1ADORA2ALMNACYP1A2CYP3A4
SCHEMBL29947063 0.78 ADORA2A (0.53) ADORA1ADORA2ALMNACYP1A2CYP3A4
SCHEMBL21621287 0.77 ADORA1 (0.39) ADORA1ADORA2ALMNACLK4TGFBR1
SCHEMBL29947005 0.77 ADORA1 (0.39) ADORA1ADORA2ALMNACLK4TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110684020-B 2-aminopyrimidine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-01-20 — — CN disclosed
Send feedback